{"id":"NCT00868530","sponsor":"Pfizer","briefTitle":"Study Evaluating On-Demand Treatment Of Xyntha In Chinese Subjects","officialTitle":"An Evaluation Of The Safety And Efficacy Of On-Demand Treatment With Xyntha (B Domain Deleted Recombinant Factor VIII, Albumin Free) In Chinese Subjects With Hemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-09","primaryCompletion":"2009-12","completion":"2009-12","firstPosted":"2009-03-25","resultsPosted":"2011-02-08","lastUpdate":"2025-06-12"},"enrollment":53,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"Xyntha","otherNames":[]}],"arms":[{"label":"Xyntha","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety and efficacy of on-demand treatment with Xyntha in Chinese hemophilia A subjects.","primaryOutcome":{"measure":"Investigator Hemostatic Efficacy Assessment 8 Hours Post Infusion","timeFrame":"8 hours post infusion","effectByArm":[{"arm":"Xyntha","deltaMin":1.86,"sd":0.65}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":6,"countries":["China"]},"refs":{"pmids":["33269010"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=3082B2-3316&StudyName=Study%20Evaluating%20On-Demand%20Treatment%20Of%20Xyntha%20In%20Chinese%20Subjects"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":53},"commonTop":["Injury","Blood potassium decreased","Diarrhea","Pyrexia","Hepatic steatosis"]}}